Abstract:Pacing and Clinical ElectrophysiologyVolume 30, Issue 12 p. 1429-1431 Discarding the Baby with the Bathwater PETER R. KOWEY M.D., F.A.C.C., PETER R. KOWEY M.D., F.A.C.C. Main Line Health Heart Center, Wynnewood, Pennsylvania Jefferson Medical College, Philadelphia, PennsylvaniaSearch for more papers by this authorGAN-XIN YAN M.D., Ph.D, F.A.C.C., GAN-XIN YAN M.D., Ph.D, F.A.C.C. Main Line Health Heart Center, Wynnewood, Pennsylvania Jefferson Medical College, Philadelphia, PennsylvaniaSearch for more papers by this author PETER R. KOWEY M.D., F.A.C.C., PETER R. KOWEY M.D., F.A.C.C. Main Line Health Heart Center, Wynnewood, Pennsylvania Jefferson Medical College, Philadelphia, PennsylvaniaSearch for more papers by this authorGAN-XIN YAN M.D., Ph.D, F.A.C.C., GAN-XIN YAN M.D., Ph.D, F.A.C.C. Main Line Health Heart Center, Wynnewood, Pennsylvania Jefferson Medical College, Philadelphia, PennsylvaniaSearch for more papers by this author First published: 06 December 2007 https://doi.org/10.1111/j.1540-8159.2007.00887.xCitations: 2 Address for reprints: Peter R. Kowey, M.D., Suite 558, Medical Office Building East, 100 Lancaster Avenue, Wynnewood, PA 19096. Fax: 610-896-0643; e-mail: [email protected] This work was partially supported by the John S. Sharpe Research Foundation and the Albert M. Greenfield Foundation. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Huang BH, Wu CH, Hsia CP, Chen PY. Azithromycin induced torsade de pointes. Pacing Clin Electrophysiol 2007; this issue. 2 Kezerashvili A, Khattak H, Barsky A, Nazari R, Fisher JD. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors. J Interv Card Electrophysiol 2007; 18: 243–246. 3 Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc Res 2003; 58: 32–45. 4 Joshi A, DiMino T, Vohra Y, Cui C, Yan GX. Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: The role of experimental models. J Electrocardiol 2004; 37 Suppl: 7–14. 5 Darpo B, Nebout T, Sager PT. Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline. J Clin Pharmacol 2006; 46: 498–507. 6 Liu T, Brown BS, Wu Y, Antzelevitch C, Kowey PR, Yan GX. Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias. Heart Rhythm 2006; 3: 948–956. 7 Viskin S, Rosovski U, Sands AJ, Chen E, Kistler PM, Kalman JM, Chavez LR, et al. Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005. 8 Bai R, Yan GX. Accurate interpretation of the QT interval: A vital task that remains unaccomplished. Heart Rhythm 2005; 2: 575–577. Citing Literature Volume30, Issue12December 2007Pages 1429-1431 ReferencesRelatedInformation

A Rare Cause of 2:1 AV Block: Long QT Syndrome

Clinical Aspects of Type 3 Long-QT Syndrome: an International Multicenter Study.

Discarding the Baby with the Bathwater

Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents with Long Qt Syndrome

Clinical Course And Risk Stratification Of Patients Affected With The Jervell And Lange-Nielsen Syndrome

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Long QT Syndrome in Adults

Risk for Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-Qt Syndrome and Normal-Range Corrected QT Intervals.

[Clinical Practice Guidelines for Long Q-T Interval Syndrome].

Clinical manifestation of neonates with acquired long QT interval associated with 2:1 A-V block

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome

Clinical Implications For Patients With Long Qt Syndrome Who Experience A Cardiac Event During Infancy

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (jervell and Lange‐Nielsen Syndrome)

Α-1-syntrophin Mutation and the Long-QT Syndrome

Cardiac Metastasis Causing Right Bundle Branch Block and Recurrent Septal Ventricular Tachycardia.

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

A new form of long QT syndrome associated with syndactyly

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events